Aricept

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

Donepezil hydrochloride

Disponibbli minn:

Pfizer Australia Pty Ltd

Klassi:

Medicine Registered

Fuljett ta 'informazzjoni

ARICEPT
®

_donepezil hydrochloride_
CONSUMER MEDICINE INFORMATION

WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Aricept. It does not
contain all the available information.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking Aricept
against the benefits they expect it
will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT ARICEPT IS USED
FOR
Aricept is used to treat mild,
moderate and severe Alzheimer's
disease, also called dementia of the
Alzheimer's type.
Aricept will not cure this disease, but
should help your memory and
improve your ability to think more
clearly.
This medicine belongs to a group of
medicines called acetylcholinesterase
inhibitors. They are thought to work
by increasing the level of a chemical
called acetylcholine in the brain.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY THIS MEDICINE
HAS BEEN PRESCRIBED FOR YOU.
Your doctor may have prescribed it
for another reason.
This medicine is not addictive.
This medicine is only available with
a doctor's prescription.
_USE IN CHILDREN_
The safety and effectiveness of
Aricept in children has not been
established.
BEFORE YOU TAKE
ARICEPT
_WHEN YOU MUST NOT TAKE IT_
DO NOT TAKE ARICEPT IF YOU HAVE AN
ALLERGY TO:
•
any medicine containing
donepezil hydrochloride
•
piperidine derivatives
•
any of the ingredients listed at the
end of this leaflet.
Some of the symptoms of an allergic
reaction may include:
•
shortness of breath
•
wheezing or difficulty breathing
•
swelling of the face, lips, tongue
or other parts of the body
•
rash, itching or hives on the skin.
DO NOT TAKE THIS MEDICINE AFTER THE
EXPIRY DATE PRINTED ON THE PACK OR
IF THE PACKAGING IS TORN OR SHOWS
SIGNS OF TAMPERING.
If it has expired or is damaged, return
it to your pharmacist for disposal.
IF YOU ARE NOT SU

Karatteristiċi tal-prodott

Version:  pfparict11112 
Supersedes:  pfparict10911 

Page 1 of 31 
PRODUCT INFORMATION 
ARICEPT

, ARICEPT
®
-D (DONEPEZIL HYDROCHLORIDE) 
NAME OF THE MEDICINE 
ARICEPT and ARICEPT-D contain the
active ingredient donepezil hydrochloride (AAN). 
The structural formula of donepezil hydrochloride is shown
below: 
.
HCl
CH
3
O
CH
3
O
O
N
CH
2
*
CH
2

Chemical name: 

(RS)-1-benzyl-4-[5,6-dimethoxy-1-indanon)-2-yl] 
-methylpiperidine hydrochloride 
Molecular formula: 

C
24
H
29
NO
3
HCl 
Molecular weight: 

415.96 
CAS Registry Number: 
120011-70-3 
DESCRIPTION 
Donepezil hydrochloride is a white crystalline powder and is freely soluble in chloroform, 
soluble in water and in glacial acetic acid, slightly soluble in ethanol and in acetonitrile and 
practically insoluble in ethyl acetate and in n-hexane. 
ARICEPT  film-coated  tablets  for  oral  administration  are  supplied  containing  5  mg  or 
10 mg  donepezil  hydrochloride  equivalent  to  4.56  mg  or  9.12  mg  donepezil  free  base, 
respectively.  The inactive ingredients are lactose, starch-maize, microcrystalline cellulose, 
hydroxypropylcellulose  and  magnesium  stearate.    The  film  coating  contains  purified  talc, 
macrogol  8000,  hypromellose  and  titanium  dioxide.    Additionally,  the  10  mg  tablet 
contains iron oxide yellow as a colouring agent. 
ARICEPT-D orally disintegrating tablets are supplied containing 5 mg or 10 mg donepezil 
hydrochloride  equivalent  to  4.56  mg  or  9.12  mg  donepezil  free  base,  respectively.    The 
inactive  ingredients  are  carrageenan,  mannitol,  silica  colloidal  anhydrous  and  polyvinyl 
alcohol.  Additionally, the 10 mg tablet contains iron
oxide yellow as a colouring agent. 
Version:  pfparict11112 
Supersedes:  pfparict10911